NeoGenomics (NEO) announced that Chris Smith will retire as CEO and board member effective April 1. Tony Zook, an independent board member since 2023, will assume the role of CEO at that time. Smith will remain with the company as an advisor throughout the transition. Zook is a partner with Lucius Partners, a healthcare consultancy.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.